Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?

  • Michael Yoon Kang, Joey Yeoh, Ashwini Pondicherry, Habib Rahman, Ajith Dissanayake
  • Journal of the Endocrine Society, July 2017, Endocrine Society
  • DOI: 10.1210/js.2017-00160

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1210/js.2017-00160